You're not wrong when you say it is hard to get a handle on the status of Prosavin.

However your article is old dated 15 December 2011 and has been superseded by the following positive high profile press release dated 12 April 2012

http://news.sky.com/story/9567/revol...for-parkinsons

Now the company are bullish about partnering to progress Prosavin, however words are cheap. It is claimed that the disappointing results of the higher doses was due to a non optimal delivery mechanism which has been overcome. This seems like a good science companŷ with appalling commercial people. Every now and then it sends press releases to sky tv and then ....nothing happens ... Infuriating company.

Neil.